Other Information
−Removed: | June 30, 2022, Form 10-Q
+Added: | September 30, 2022, Form 10-Q
Exhibit Description
2 unchanged sentences
Amendment to the Amended and Restated Articles of Incorporation of the Registrant as amended on August 2, 2014 (incorporated by reference to Exhibit 3.3 to the Company’s Post-Effective Amendment No.1 to Form S-3 filed on January 22, 2021).
−Removed: License Agreement entered into on May 10, 2022 by and between Jawaharlal Nehru Centre For Advanced Scientific Research, Bengaluru and Hamsa Biopharma India Private Limited, Delhi (incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K filed on May 12, 2022).
Rule 13a-14(a) / 15d-14(a) Certification of Chief Executive Officer.
10 unchanged sentences
** Furnished herewith.
−Removed: | June 30, 2022, Form 10-Q
+Added: | September 30, 2022, Form 10-Q
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
INDIA GLOBALIZATION CAPITAL, INC.
−Removed: August 5, 2022
+Added: November 1, 2022
/s/ Ram Mukunda
1 unchanged sentence
(Principal Executive Officer)
−Removed: August 5, 2022
+Added: November 1, 2022
/s/ Claudia Grimaldi
2 unchanged sentences
(Principal Financial Officer)
−Removed: | June 30, 2022, Form 10-Q
+Added: | September 30, 2022, Form 10-Q
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.